SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000850261-20-000042
Filing Date
2020-06-15
Accepted
2020-06-15 18:09:09
Documents
1
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159225892982664.html 4  
1 FORM 4 wf-form4_159225892982664.xml 4 4089
  Complete submission text file 0000850261-20-000042.txt   5570
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O SORRENTO THERAPEUTICS, INC. 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address
Wu Yue Alexander (Reporting) CIK: 0001682419 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 20964431